MENU
Showcases Stock ranks Forex

Glaxosmithkline Plc ADR (GSK)
39.77  0.22 (0.56%) 10-22 16:00
Open: 39.63 Pre. Close: 39.55
High: 39.81 Low: 39.59
Volume: 4,820,456 Market Cap: 100,056M
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 39.814 - 39.953 39.953 - 40.08
Low: 39.182 - 39.365 39.365 - 39.532
Close: 39.484 - 39.735 39.735 - 39.966
Stock Technical Analysis
Overall:     
Target: Six months: 46.50
One year: 54.31
Support: Support1: 38.57
Support2: 37.80
Resistance: Resistance1: 39.81
Resistance2: 46.50
Pivot: 38.81
Moving Averages: MA(5): 39.32
MA(20): 38.67
MA(100): 39.87
MA(250): 38.09
MACD: MACD(12,26):
Signal(12,26,9): -0.21
%K %D: %K(14,3): 97.43
%D(3): 90.72
RSI: RSI(14): 59.87
52-Week: High: 42.68
Low: 33.26
Change(%): 12.9
Average Vol(K): 3-Month: 364827
10-Days: 435094
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.

GSK has closed above the upper band by 0.1%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 10.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Thu, 21 Oct 2021
Glaxosmithkline (GSK) gains 0.23% in Active Trading on October 21 - Equities.com

Mon, 18 Oct 2021
Glaxosmithkline (GSK) falls 0.92% for October 18 - Equities.com

Wed, 13 Oct 2021
Glaxosmithkline (GSK) gains 0.41% on Strong Volume October 13 - Equities.com

Tue, 12 Oct 2021
CureVac Stock Drops; Firm Ends Development of Covid mRNA Vaccine - TheStreet

Tue, 12 Oct 2021
Glaxo Stock Higher on Reported Plan to Field PE Bids for Consumer Unit - TheStreet

Mon, 11 Oct 2021
GSK (GlaxoSmithKline PLC ADR) - Morningstar.com

Financial Analysis
Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers—General
Shares Out. (M) 2520.00
Shares Float (M) 2450.00
% Held by Insiders 0.01
% Held by Institutions 12.64
Shares Short (K) 18630
Shares Short Prior Month (K) 23600
Stock Financials
EPS 2.910
Book Value (p.s.) 5.940
Profit Margin 16.21
Operating Margin 23.63
Return on Assets (ttm) 5.9
Return on Equity (ttm) 29.0
Qtrly Rev. Growth -18.4
Gross Profit (p.s.) 9.210
Sales Per Share 12.869
EBITDA (p.s.) 3.857
Qtrly Earnings Growth -31.40
Operating Cash Flow (M) 7810.00
Levered Free Cash Flow (M) 8900.00
Stock Valuation
PE Ratio 13.67
PEG Ratio
Price to Book value 6.70
Price to Sales 3.09
Price to Cash Flow 12.83
Stock Dividends
Dividend 0.800
Dividend Yield 0.02
Dividend Growth 2.170

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator